Cycles of antibiotic use and emergent antimicrobial resistance in the South African tuberculosis programme (1950-2021): A scoping review and critical reflections on stewardship

References

• Adams, V., Behague, D., Caduff, C., Löwy, I., & Ortega, F. (2019). Re-imagining global health through social medicine. Global Public Health, 14(10), 1383–1400. https://doi.org/10.1080/17441692.2019.1587639
   PubMed Web of Science ®Google Scholar
• Alliance for Health Policy and Systems Research. (2017). Primary Health Care Systems Case Study from South Africa. World Health Organization, 1–12.
   Google Scholar
• Amrith, S. (2004). In search of a ‘Magic Bullet’ for tuberculosis: South India and Beyond, 1955–1965. Social History of Medicine, 17(1), 113–130. https://doi.org/10.1093/shm/17.1.113
   Web of Science ®Google Scholar
• Andrews, J., Basu, S., Scales, D., Maru, D. S.-R., & Subbaraman, R. (2007). XDR-TB in South Africa: No time for denial or complacency. PLoS Medicine, 4(1), 0019–0025. https://doi.org/10.1371/journal.pmed.0040050
   Web of Science ®Google Scholar
• Arksey, H., & O’Malley, L. (2005). Scoping studies: Towards a methodological framework. International Journal of Social Research Methodology: Theory and Practice, 8(1), 19–32. https://doi.org/10.1080/1364557032000119616
   Google Scholar
• Atwell, A. G., & Pearson, P. J. O. (1980). Routine outpatient short-course chemotherapy for pulmonary tuberculosis. A radiographic presentation. South African Medical Journal, 58(26), 1041–1046. https://doi.org/10.10520/AJA20785135_12088
   PubMed Web of Science ®Google Scholar
• Ayles, H., Mureithi, L., & Simwinga, M. (2022). The state of tuberculosis in South Africa: What does the first national tuberculosis prevalence survey teach us? The Lancet Infectious Diseases, 22(8), 1094–1096. https://doi.org/10.1016/S1473-3099(22)00286-9
   PubMed Web of Science ®Google Scholar
• Bateman, C. (2007). XDR-TB or not XDR-TB? That is the question. South African Medical Journal, 97(5), 318–322,318,320,320,322. https://doi.org/10.1016/j.meegid.2011.07.019
   PubMed Web of Science ®Google Scholar
• Bell, J., & Yach, D. (1988). Tuberculosis patient compliance in the western Cape, 1984. South African Medical Journal, 73(1), 31–33. https://doi.org/10.10520/AJA20785135_8879
   PubMed Web of Science ®Google Scholar
• Benatar, S. R. (1982). Tuberculosis in the 1980s, with particular reference to South Africa. South African Medical Journal, 62(11), 359–364. https://doi.org/10.10520/AJA20785135_7455
   PubMed Web of Science ®Google Scholar
• Berhanu, R., Schnippel, K., Mohr, E., Hirasen, K., Evans, D., Rosen, S., & Sanne, I. (2016). Early outcomes of decentralized care for rifampicin-resistant tuberculosis in Johannesburg, South Africa: An observational cohort study. PLoS ONE, 11(11), https://doi.org/10.1371/journal.pone.0164974
   Web of Science ®Google Scholar
• Biehl, J. (2007). Pharmaceuticalization: AIDS treatment and global health politics. Anthropological Quarterly, 80(4), 1083–1126. https://doi.org/10.1353/anq.2007.0056
   Web of Science ®Google Scholar
• Bouton, T. C., de Vos, M., Ragan, E. J., White, L. F., van Zyl, L., Theron, D., Robert Horsburgh, C., Warren, R. M., & Jacobson, K. R. (2019). Switching to bedaquiline for treatment of rifampicin-resistant tuberculosis in South Africa: A retrospective cohort analysis. PLoS ONE, 14(10), 1–6. https://doi.org/10.1371/journal.pone.0223308
   Web of Science ®Google Scholar
• Bowker, G. C., & Star, S. L. (1970). Sorting things out: Classification and its consequences. The American journal of nursing, 70(8), https://doi.org/10.2307/3421475
   Google Scholar
• Broom, A., Broom, J., Kirby, E., Gibson, A., & Davis, M. (2017). Health & place antibiotic optimisation in ‘ the bush ‘ : Local know-how and core–periphery relations. Health & Place, 48, 56–62. https://doi.org/10.1016/j.healthplace.2017.09.003
   PubMed Web of Science ®Google Scholar
• Broom, A., Kenny, K., Prainsack, B., & Broom, J. (2021). Antimicrobial resistance as a problem of values? Views from three continents. Critical Public Health, 31(4), 451–463. https://doi.org/10.1080/09581596.2020.1725444
   Web of Science ®Google Scholar
• Bud, R. (2007). Penicillin: triumph and tragedy. Oxford University Press.
   Google Scholar
• Chandler, C. I. R. (2019). Current accounts of antimicrobial resistance: Stabilisation, individualisation and antibiotics as infrastructure. Palgrave Communications, 5(53), 15–17. https://doi.org/10.1057/s41599-019-0263-4
   Google Scholar
• Chiang, C. Y., Chiang, C. Y., Chiang, C. Y., Trébucq, A., Piubello, A., Rieder, H. L., Rieder, H. L., Schwoebel, V., van Deun, A., & van Deun, A. (2020). The looming threat of bedaquiline resistance in tuberculosis. European Respiratory Journal, 55(6), 3–5. https://doi.org/10.1183/13993003.00718-2020
   Web of Science ®Google Scholar
• Cluver, F. W. P. (1965). The scourge of tuberculosis. South African Medical Journal, 39(9), 181–182. https://journals.co.za/doi/epdf/10.10520AJA20785135_37871
   Google Scholar
• Coetzee, G., & Koornhof, H. (2006). MDR / XDR tuberculosis in South Africa. Southern African Journal of Epidemiology and Infection, 21(3), 150–151. https://doi.org/10.10520/EJC80747
   Google Scholar
• Collins, T. F. (1972). The new approach to tuberculosis. South African Medical Journal, 46(10), 260–261. https://doi.org/10.10520/AJA20785135_31877
   PubMed Web of Science ®Google Scholar
• Collins, T. F. (1982). The history of southern Africa’s first tuberculosis epidemic. South African Medical Journal, 62(21), 780–788. https://doi.org/10.10520/AJA20785135_7579
   PubMed Web of Science ®Google Scholar
• Comaroff, J. (2007). Beyond Bare Life: AIDS, (Bio)Politics, and the Neoliberal Order. Public Culture, 19(1), 197–219. doi:10.1215/08992363-2006-030
   Web of Science ®Google Scholar
• Conradie, F., Meintjes, G., Hughes, J., Maartens, G., Ferreira, H., Siwendu, S., Master, I., & Ndjeka, N. (2014). Clinical access to Bedaquiline Programme for the treatment of drug-resistant tuberculosis. South African Medical Journal, 104(3), 164–166. https://doi.org/10.7196/samj.7263
   PubMed Web of Science ®Google Scholar
• Cooper, E. D. (1954). The domiciliary treatment of pulmonary tuberculosis as a public service. South African Medical Journal, 28(10), 1954. https://journals.co.za/doi/10.10520AJA20785135_30257
   Google Scholar
• Coovadia, H., Jewkes, R., Barron, P., Sanders, D., & Mcintyre, D. (2009). The health and health system of South Africa: historical roots of current public health challenges. The Lancet, 374(9692), 817–834. https://doi.org/10.1016/S0140-6736(09)60951-X
   PubMed Web of Science ®Google Scholar
• Cox, H., Dickson-Hall, L., Jassat, W., Moshabela, M., Kielman, K., Grant, A., Nicol, M., Black, J., Mlisana, K., Vanleeuw, L., & Loveday, M. (2017a). Drug-resistant tuberculosis in South Africa: History, progress and opportunities for achieving universal access to diagnosis and effective treatment. South African Health Review, 20, 157–168.
   Google Scholar
• Cox, J. A., Vlieghe, E., Mendelson, M., Wertheim, H., Ndegwa, L., Villegas, M. V., Gould, I., & Levy Hara, G. (2017b). Antibiotic stewardship in low- and middle-income countries: The same but different? Clinical Microbiology and Infection, 23(11), 812–818. https://doi.org/10.1016/j.cmi.2017.07.010
   PubMed Web of Science ®Google Scholar
• Crowhurst Archer, B. (1960). The psychiatric approach to rehabilitation. South African Medical Journal, 34(3), 242–244. https://doi.org/10.10520/AJA20785135_41438
   Google Scholar
• de Lange, M. (2006). Tuberculosis and the emergence of drug resistance. Professional Nursing Today, 10(5), 3–5.
   Google Scholar
• Denyer Willis, L., & Chandler, C. (2019). Quick fix for care, productivity, hygiene and inequality: Reframing the entrenched problem of antibiotic overuse. BMJ Case Reports, 4(4), 1–6. https://doi.org/10.1136/bmjgh-2019-001590
   Google Scholar
• de Villiers, J. P. (1957). The Tuberculosis problem in South Africa in the light of recent advances. South African Medical Journal, 31(50), 1274–1277. https://journals.co.za/doi/epdf/10.10520AJA20785135_44814
   PubMedGoogle Scholar
• Dixon, J., Manyau, S., Kandiye, F., Kranzer, K., Clare, I., & Chandler, R. (2021). Antibiotics, rational drug use and the architecture of global health in Zimbabwe. Social Science & Medicine, 272, 113594. https://doi.org/10.1016/j.socscimed.2020.113594
   PubMed Web of Science ®Google Scholar
• Dormer, B. A. (1960). Tuberculosis. South African Medical Journal, 34(15), 291–294. https://doi.org/10.10520/AJA20785135_41586
   PubMedGoogle Scholar
• Dormer, B. A., & Salinger, P. L. (1971). A comparative trial with combinations of rifampicin, ethambutol and isoniazid (hydronsan) in previously untreated cases of pulmonary tuberculosis. South African Medical Journal, 45(25), 697–699. https://doi.org/10.10520/AJA20785135_31334
   PubMedGoogle Scholar
• Escreet, B. C., & Cowie, R. L. (1981). Short-course chemotherapy for pulmonary tuberculosis - a 100-day interrupted regimen. South African Medical Journal, 60(25), 951–955. https://doi.org/10.10520/AJA20785135_14165
   PubMed Web of Science ®Google Scholar
• Evans, D., Sineke, T., Schnippel, K., Berhanu, R., Govathson, C., Black, A., Long, L., Rosen, S., EvansDenise, S. T., Schnippel, K., Berhanu, R., Govathson, C., Black, A., Long, L., Rosen, S., Evans, D., Sineke, T., Schnippel, K., … Rosen, S. (2018). Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa. BMC Health Services Research, 18(1), 973. https://doi.org/10.1186/s12913-018-3762-x
   Google Scholar
• Farmer, P. (1997). Social scientists and the new tuberculosis. Social Science & Medicine (1982), 44(3), 347–358. doi:10.1016/S0277-9536(96)00143-8
   PubMed Web of Science ®Google Scholar
• Fatti Crawshaw, V. H., Reginald, G. R., & Wilson, H. V. (1950). Pulmonary tuberculosis : The results of treatment at Baragwanath Non-European Hospital. South African Medical Journal, 24(51), 1065–1069. https://doi.org/10.10520/AJA20785135_25810
   PubMedGoogle Scholar
• Ferguson, D. L. (1960). Health Education in South Africa. South African Medical Journal, 34(3), 263–264.
   PubMedGoogle Scholar
• Foster, K. E. (2005). Clinics, communities, and cost recovery: Primary health care and neoliberalism in postapartheid South Africa. Cultural Dynamics, 17(3), 239–266. https://doi.org/10.1177/0921374005061990
   Google Scholar
• Fox, W., Ellard, G. A., & Mitchison, D. A. (1999). Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units, 1946-1986, with relevant subsequent publications. The International Journal of Tuberculosis and Lung Disease, 3(2), S231–S279(49).
   PubMedGoogle Scholar
• Geffen, N. (2016). Anything to stay alive: The challenges of a campaign for an experimental drug. Developing World Bioethics, 16(1), 45–54. https://doi.org/10.1111/dewb.12084
   PubMed Web of Science ®Google Scholar
• Gordon, T., Booysen, F., & Mbonigaba, J. (2020). Socio-economic inequalities in the multiple dimensions of access to healthcare: The case of South Africa. BMC Public Health, 20(1), 1–13. https://doi.org/10.1186/s12889-020-8368-7
   PubMed Web of Science ®Google Scholar
• Gradmann, C. (2019). Treatment on trial: Tanzania’s national tuberculosis program, the international union against Tuberculosis and Lung Disease, and the Road to DOTS, 1977-1991. Journal of the History of Medicine and Allied Sciences, 74(3), 316–343. https://doi.org/10.1093/JHMAS/JRZ029
   PubMed Web of Science ®Google Scholar
• Griffiths, M. L., & Makgothi, M. M. (1981). Tuberculosis management in a rural community - factors in failure. South African Medical Journal, 59(1), 14–16. https://doi.org/10.10520/AJA20785135_13526
   PubMed Web of Science ®Google Scholar
• Grusin, H. (1966). The results of treatment of pulmonary tuberculosis among Africans. South African Medical Journal, 40(26), 617–620. https://doi.org/10.10520/AJA20785135_37386
   PubMedGoogle Scholar
• Harrison, D. (1993). The National Health Services Conunission, 1942-1944-its origins and outcome. South African Medical Journal, 83, 679–684.
   PubMed Web of Science ®Google Scholar
• Holland, M. D. (1972). Rifampicin - what dose for pulmonary tuberculosis? South African Medical Journal, 46(20), 604–608.
   PubMed Web of Science ®Google Scholar
• Human, S. P., Smith, J. E., & Tshabalala, D. L. (2010). Factors influencing tuberculosis treatment interruptions. Africa Journal of Nursing and Midwifery, 12(2), 48–57. https://doi.org/10.10520/EJC19353
   Google Scholar
• IACG (Interagency Coordination Group on Antimicrobial Resistance). (2019). No Time to Wait: Securing the Future from Drug-Resistant Infections: Report to the Secretary- General of the United Nations.
   Google Scholar
• Johnson & Johnson. (2023). Safeguarding medicines for multidrug-resistant tuberculosis (MDR-TB) treatment.
   Google Scholar
• Jones, K. D. J., Hesketh, T., & Yudkin, J. (2008). Extensively drug-resistant tuberculosis in sub-Saharan Africa: an emerging public-health concern. Transactions of the Royal Society of Tropical Medicine and Hygiene, 102(3), 219–224. https://doi.org/10.1016/j.trstmh.2007.11.014
   PubMed Web of Science ®Google Scholar
• Kandel, T. R., Mfenyana, K., Chandia, J., & Yogeswaran, P. (2008). The prevalence of and reasons for interruption of anti-tuberculosis treatment by patients at Mbekweni Health Centre in the King Sabata Dalindyebo (KSD) District in the Eastern Cape province : original research. South African Family Practice, 50(6), 47. doi:10.1080/20786204.2008.10873785
   Google Scholar
• Kent, P. (1982). The relevance of short-course tuberculosis chemotherapy to the African situation. South African Medical Journal, 62, 8–12. https://doi.org/10.10520/AJA20785135_7410
   Google Scholar
• London, L. (2009). Confinement for extensively drug-resistant tuberculosis: Balancing protection of health systems, individual rights and the public’s health. International Journal of Tuberculosis and Lung Disease, 13(10), 1200–1209.
   PubMed Web of Science ®Google Scholar
• Loveday, M., & Cox, H. (2013). Carpe diem (‘Seize the day’): Building on the findings of the 2015 World Health Organization evaluation of the multidrug-resistant tuberculosis (MDR-TB) programme to make the most of shortened MDR-TB treatment in South Africa. South African Medical Journal, 107(3), 299–307. https://doi.org/10.5588/ijtld.12.0537
   Google Scholar
• Lönnroth, K., Jaramillo, E., Williams, B. G., Dye, C., & Raviglione, M. (2009). Drivers of tuberculosis epidemics: The role of risk factors and social determinants. Social Science and Medicine, 68(12), 2240–2246. https://doi.org/10.1016/j.socscimed.2009.03.041
   PubMed Web of Science ®Google Scholar
• Lu, X., Smare, C., Kambili, C., el Khoury, A. C., & Wolfson, L. J. (2017). Health outcomes of bedaquiline in the treatment of multidrug-resistant tuberculosis in selected high burden countries. BMC Health Services Research, 17(1), 87. https://doi.org/10.1186/s12913-016-1931-3
   PubMedGoogle Scholar
• Mabin, A. (1992). Comprehensive segregation: The origins of the group areas act and its planning apparatuses. Journal of Southern African Studies, 18(2), 405–429. https://doi.org/10.1080/03057079208708320
   Web of Science ®Google Scholar
• MacPherson, E. E., Reynolds, J., Sanudi, E., Nkaombe, A., Phiri, C., Mankhomwa, J., Dixon, J., & Chandler, C. I. R. (2022). Understanding antimicrobial resistance through the lens of antibiotic vulnerabilities in primary health care in rural Malawi. Global Public Health, 2630–2646. https://doi.org/10.1080/17441692.2021.2015615
   PubMed Web of Science ®Google Scholar
• Marais, D. P. (1960). Whither Tuberculosis. South African Medical Journal, 34(6), 509–511. https://doi.org/10.10520/AJA20785135_41205
   PubMedGoogle Scholar
• María Jesús Santesmases. (2017). The Circulation of Penicillin in Spain: Health, Wealth and Authority. Palgrave Macmillan. http://www.palgrave.com/gp/series/15183.
   Google Scholar
• McMillen, C. (2015). Tuberculosis: A global history, 1900 to present. Yale University Press.
   Google Scholar
• Monnais, L. (2019). The colonial life of pharmaceuticals: Medicines and modernity in Vietnam. Cambridge University Press. https://doi.org/10.1017/9781108567152
   Google Scholar
• Monnais, L., & Tousignant, N. (2006). The colonial life of pharmaceuticals: Accessibility to healthcare, consumption of medicines, and medical pluralism in French Vietnam, 1905––1945. Journal of Vietnamese Studies, 1(1–2), 131–166. https://doi.org/10.1525/vs.2006.1.1-2.131
   Google Scholar
• Ndjeka, N., Conradie, F., Schnippel, K., Hughes, J., Bantubani, N., Ferreira, H., Maartens, G., Mametja, D., Meintjes, G., Padanilam, X., Variava, E., Pym, A., & Pillay, Y. (2015). Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: An interim cohort analysis. The International Journal of Tuberculosis and Lung Disease : The Official Journal of the International Union against Tuberculosis and Lung Disease, 19(8), 979–985. https://doi.org/10.5588/ijtld.14.0944
   PubMed Web of Science ®Google Scholar
• Nguyen, V.-K. (2010). The republic of therapy: Triage and Sovereignty in West Africa’s Time of AIDS. Duke University Press.
   Google Scholar
• Njaramba, P., & Naidoo, S. (2007). Managing multidrug-resistant tuberculosis in hospitalised patients: A review of treatment outcomes. Southern African Journal of Epidemiology and Infection, 22(2), 39–44. https://doi.org/10.1080/10158782.2007.11441283
   Google Scholar
• Olayanju, O., Limberis, J., Esmail, A., Oelofse, S., Gina, P., Pietersen, E., Fadul, M., Warren, R., & Dheda, K. (2018). Long-term bedaquiline-related treatment outcomes in patients with extensively drug-resistant tuberculosis from South Africa. European Respiratory Journal, 51(5), 1800544. https://doi.org/10.1183/13993003.00544-2018
   PubMed Web of Science ®Google Scholar
• O’Neill, J. (2016). Tackling Drug-Resistant Infections Globally: Final Report and Recommendations.
   Google Scholar
• Packard, R. (1989). White plague, black labor: Tuberculosis and the political economy of health and disease in South Africa. University of California Press.
   Google Scholar
• Packard, R. (2016a). A history of global health: Interventions into the lives of other peoples. Johns Hopkins Press.
   Google Scholar
• Packard, R. (2016b). Back to the future: From international to global health. In A History of Global Health (pp. 267–328). Johns Hopkins University Press.
   Google Scholar
• Palanco Lopez, P., Manyau, S., Dixon, J., Nayiga, S., Manton, J., Kirchhelle, C., & & Chandler, C. I. R. (2022). Antibiotic arrivals in Africa: A case study of yaws and syphilis in Malawi, Zimbabwe and Uganda. Medicine Anthropology Theory, 9(3), 1–31. doi:10.17157/mat.9.3.5633
   Google Scholar
• Pearson, J. O. (1977). The practical benefits of updated medical control of pulmonary tuberculosis. South African Medical Journal, 52(13), 510. https://journals.co.za/doi/pdf/10.10520AJA20785135_18082
   PubMed Web of Science ®Google Scholar
• Pearson, M., & Chandler, C. (2019). Knowing antmicrobial resistance in practice: A multi-country qualitative study with human and animal healthcare professionals. Global Health Action, 12(1), 1599560. https://doi.org/10.1080/16549716.2019.1599560
   PubMedGoogle Scholar
• Phillips, H. (2014). The return of the pholela experiment: Medical history and primary health care in post-apartheid South Africa. American Journal of Public Health, 104(10), 1872–1876. https://doi.org/10.2105/AJPH.2014.302136
   PubMed Web of Science ®Google Scholar
• Podolsky, S. H. (2015). The antibiotic era: Reform, resistance, and the pursuit of a rational therapeutics. Journal of Chemical Information and Modeling, 53(9).
   Google Scholar
• Ponthieu, A., & Incerti, A. (2016). Continuity of care for migrant populations in Southern Africa. Refugee Survey Quarterly, 35(2), 98–115. https://doi.org/10.1093/rsq/hdw006
   Google Scholar
• Poots, E. (2012). Strategy for Tackling Antimicrobial Resistance (STAR) 2012-2017.
   Google Scholar
• Prince, R. J., & Marsland, R. (2013). Making and unmaking public health in Africa: Ethnographic and historical perspectives. Ohio University Press. https://books.google.co.uk/books?id=UvnonQEACAAJ
   Google Scholar
• Salinger, P. L., & Dormer, B. (1972). Rifampicin, ethambutol, ethionamide and hydronsan in advanced pulmonary tuberculosis. South African Medical Journal, 46(13), 354–358. https://doi.org/10.10520/AJA20785135_31735
   PubMed Web of Science ®Google Scholar
• Saville-Lewis, J. (1953). Tuberculosis in East London : With particular reference to the Santa tuberculosis settlement, Fort Grey, and its relation to tuberculosis control. South African Medical Journal, 27(44), 980–983. https://journals.co.za/doi/10.10520AJA20785135_29055
   PubMedGoogle Scholar
• Snyman, L., Venables, E., Trivino Duran, L., Mohr, E., Azevedo, V. D., Harmans, X., & Isaakidis, P. (2018). “I didn’t know so many people cared about me”: Support for patients who interrupt drug-resistant TB treatment. The International Journal of Tuberculosis and Lung Disease : The Official Journal of the International Union against Tuberculosis and Lung Disease, 22(9), 1023–1030. https://doi.org/10.5588/ijtld.17.0826
   PubMed Web of Science ®Google Scholar
• StatsSA. (2018). Mid-year population estimates. In StatsSA.
   Google Scholar
• The Joanna Briggs Institute. (2015). The Joanna Briggs Institute Reviewers’ Manual 2015: Methodology for JBI scoping reviews. Joanne Briggs Institute, 1–24. www.joannabriggs.org.
   Google Scholar
• Van Rensburg, D., Janse van Rensburg-Bonthuyzen, E., Heunis, C., & Meulemans, H. (2005). Tuberculosis control in South Africa: Reasons for persistent failure. Acta Academica, 2005(1), 1–55. https://doi.org/10.10520/EJC15071
   Google Scholar
• Weyer, K., & Stander, M. F. (1996). Multidrug resistant tuberculosis in South Africa. The Lancet, 348(9042), 1658. doi:10.1016/S0140-6736(05)65720-0
   PubMed Web of Science ®Google Scholar
• Whitehouse, A. B. (1980). Modern management of tuberculosis in a rural area. South African Medical Journal, 58(17), 695–696. https://journals.co.za/doi/epdf/10.10520AJA20785135_16345
   PubMed Web of Science ®Google Scholar
• WHO. (2014). Antimicrobial Resistance: Global Report of Surveillance. https://doi.org/10.1016/j.giec.2020.06.004
   Google Scholar
• WHO. (2015). Global action plan on antimicrobial resistance. Microbe Magazine, 10(9), 354–355. https://doi.org/10.1128/microbe.10.354.1
   Google Scholar
• WHO. (2020). WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment. Online annexes. In Who.
   Google Scholar
• WHO. (2022a). Global Tuberculosis Report 2022. In Geneva: World Health organization.
   Google Scholar
• WHO. (2022b). WHO consolidated guidelines on tuberculosis Module 4: Treatment Drug-resistant tuberculosis treatment 2022 update.
   Google Scholar
• Wilkinson, A., Ebata, A., & Macgregor, H. (2018). Interventions to reduce antibiotic prescribing in LMICs: A scoping review of evidence from human and animal health systems. Antibiotics, 8(1), https://doi.org/10.3390/antibiotics8010002
   Google Scholar
• Wilkinson, D., & de Cock, K. M. (1996). Tuberculosis control in South Africa - time for a new paradigm? South African Medical Journal, 86(1), 33–35.
   PubMed Web of Science ®Google Scholar
• Wilkinson, D., Pillay, M., Davies, G. R., & Sturm, A. W. (1996). Resistance to antituberculosis drugs in rural South Africa: Rates, patterns, risks, and transmission dynamics. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90(6), 692–695. https://doi.org/10.1016/S0035-9203(96)90440-X
   PubMed Web of Science ®Google Scholar
• Wise, J. (2006). Southern Africa is moving swiftly to combat the threat of XDR-TB. Bulletin of the World Health Organization, 84(12), 924–925.
   PubMed Web of Science ®Google Scholar
• Wood, R., Lawn, S. D., Johnstone-Robertson, S., & Bekker, L. G. (2011). Tuberculosis control has failed in South Africa - time to reappraise strategy. South African Medical Journal, 101(2), 111–114. https://doi.org/10.7196/SAMJ.4587
   PubMed Web of Science ®Google Scholar
• World Bank Group. (2021). Antimicrobial Resistance (AMR). World Bank Brief. https://www.worldbank.org/en/topic/health/brief/antimicrobial-resistance-amr.
   Google Scholar
• Yeats, J. R. (1986). Attendance compliance for short-course tuberculosis chemotherapy at clinics in Estcourt and surroundings. South African Medical Journal, 70(2), 265–266. https://doi.org/10.10520/AJA20785135_3607
   PubMedGoogle Scholar
• Zabow, M., & Pearson, J. O. (1982). Short-course chemotherapy for pulmonary tuberculosis - points of interest. South African Medical Journal, 61(23), 867–870. https://doi.org/10.10520/AJA20785135_14684
   PubMed Web of Science ®Google Scholar